Literature DB >> 2387027

Inhibitory effect of sinigrin and indole-3-carbinol on diethylnitrosamine-induced hepatocarcinogenesis in male ACI/N rats.

T Tanaka1, Y Mori, Y Morishita, A Hara, T Ohno, T Kojima, H Mori.   

Abstract

The modifying effects of sinigrin (Sin) and indole-3-carbinol (I3C) on the hepatocarcinogenesis induced by diethylnitrosamine (DEN) were investigated in male ACI/N rats. Rats were divided into six groups: group 1 was given DEN (40 p.p.m.) in the drinking water for 5 weeks, starting at 7 weeks of age; group 2 was treated with DEN and diet containing 1200 p.p.m. Sin; group 3 received DEN and diet containing 1000 p.p.m. I3C; group 4 was given Sin diet alone; group 5 was given I3C diet alone; and group 6 served as controls. The diet containing Sin or I3C was fed to the rats starting at 6 weeks of age until 1 week after the carcinogen exposure. At termination of the experiment (week 29), the incidences of iron-excluding altered foci (11.22 +/- 3.22/cm2) and liver cell tumors (6/12, 50%) and the tumor multiplicity (0.9/rat) in rats of group 2 were significantly smaller than those of group 1 (foci incidence, 48.33 +/- 6.34/cm2, tumor incidence, 10/10, 100%; multiplicity, 9.5/rat) (P less than 0.02). Similarly, the incidence of iron-excluding hepatocellular foci (17.65 +/- 4.67/cm2) and tumor multiplicity (2.4/rat) with a slight reduction of tumor incidence (9/12, 75%) in rats of group 3 were significantly lower than those of group 1 (P less than 0.001). There were no liver cell neoplasms in rats of groups 4, 5 and 6. Thus, Sin and I3C inhibited the hepatocarcinogenesis induced by DEN when they were administered concurrently with the carcinogen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2387027     DOI: 10.1093/carcin/11.8.1403

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

Review 1.  Allyl isothiocyanate as a cancer chemopreventive phytochemical.

Authors:  Yuesheng Zhang
Journal:  Mol Nutr Food Res       Date:  2010-01       Impact factor: 5.914

Review 2.  Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs.

Authors:  Stephen Safe; Sabitha Papineni; Sudhakar Chintharlapalli
Journal:  Cancer Lett       Date:  2008-05-22       Impact factor: 8.679

Review 3.  Perspectives in cancer chemoprevention.

Authors:  G D Stoner; M A Morse; G J Kelloff
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

4.  Anti-proliferative activities of sinigrin on carcinogen-induced hepatotoxicity in rats.

Authors:  Meng Jie; Wan Man Cheung; Vivian Yu; Yanling Zhou; Pak Ho Tong; John W S Ho
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

5.  Suppressive effect of the angiogenesis inhibitor TNP-470 on the development of carcinogen-induced hepatic nodules in rats.

Authors:  T Ikebe; T Yamamoto; S Kubo; K Hirohashi; H Kinoshita; K Kaneda; M Sakurai
Journal:  Jpn J Cancer Res       Date:  1998-02

6.  Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.

Authors:  T Tanaka; T Kojima; Y Morishita; H Mori
Journal:  Jpn J Cancer Res       Date:  1992-08

7.  Inhibitory effects of benzyl isothiocyanate and benzyl thiocyanate on diethylnitrosamine-induced hepatocarcinogenesis in rats.

Authors:  S Sugie; A Okumura; T Tanaka; H Mori
Journal:  Jpn J Cancer Res       Date:  1993-08

8.  Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats.

Authors:  D J Kim; K K Lee; B S Han; B Ahn; J H Bae; J J Jang
Journal:  Jpn J Cancer Res       Date:  1994-06

9.  Chemopreventive effects of taurine on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats.

Authors:  K Okamoto; S Sugie; M Ohnishi; H Makita; T Kawamori; T Watanabe; T Tanaka; H Mori
Journal:  Jpn J Cancer Res       Date:  1996-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.